Is ADMS A Good Stock To Buy Now?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth...
Adamas Pharmaceuticals Inc (ADMS)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 2,742,000 | $11,873 | 0.4% | |
| 2. | Opaleye Management James A. Silverman | 1,487,800 | $6,442 | 0.84% | |
| 3. | Renaissance Technologies Jim Simons | 898,584 | $3,891 | +10% | 0% |
| 4. | AIGH Investment Partners Orin Hirschman | 875,851 | $3,793 | 1.54% | |
| 5. | Stonepine Capital Timothy P. Lynch | 808,431 | $3,501 | +23% | 2.68% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.98 | 3,850 | Officer, Director | 199,242 | 2018-11-07 | Filing | |
| $16.81 | 8,240 | Large Shareholder, Director | 4,031,804 | 2016-09-16 | Filing | |
| $16.50 | 200 | Large Shareholder, Director | 4,023,564 | 2016-09-15 | Filing | |
| $16.43 | 54,537 | Large Shareholder, Director | 4,023,364 | 2016-09-14 | Filing | |
| $16.81 | 8,240 | Large Shareholder | 4,031,804 | 2016-09-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.36 | 3,821 | Officer | 72,439 | 2021-02-01 | Filing | |
| $6.39 | 4,514 | Officer | 95,486 | 2021-02-01 | Filing | |
| $4.41 | 2,630 | Officer | 76,260 | 2021-01-20 | Filing | |
| $3.21 | 2,050 | Officer | 78,890 | 2020-11-02 | Filing | |
| $5.92 | 1,269 | Officer | 70,940 | 2020-01-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,107,225 | $4,794 | 0% | |
| 2. | 973,612 | $4,216 | 0% | |
| 3. | 534,913 | $2,316 | 0% | |
| 4. | 355,079 | $1,537 | 0% | |
| 5. | 278,011 | $1,204 | 0.14% |
News See All
Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy ?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second...
Hedge Funds Are Dumping Adamas Pharmaceuticals Inc (ADMS)
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts, usually don't make them change their opinion towards...
Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds and investors' positions...
Market Movers Today: Switch Inc (SWCH), Longfin Corp (LFIN), Cellectis SA (ADR) (CLLS), Adamas Pharmaceuticals Inc (ADMS), and More
What happened: Shares of Switch (NYSE:SWCH) have gotten crushed today, down by 16% as of 12:20 p.m. EDT, after the data center specialist reported fourth-quarter earnings. Net losses were worse than expected...
Market Movers Today: Immersion Corporation (IMMR), Trade Desk Inc (TTD), Blue Buffalo Pet Products Inc (BUFF), and More
What happened: Shares of Immersion Corporation (NASDAQ:IMMR) have surged today, up by 13% as of 11:20 a.m. EST, after it reported fourth-quarter earnings last night. The company was able to narrow its...
13G Filing: Kerrisdale Capital and Adamas Pharmaceuticals Inc (ADMS)
above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection...
13G Filing: Point72 Asset Management and Adamas Pharmaceuticals Inc (ADMS)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing...
13G Filing: Great Point Partners and Adamas Pharmaceuticals Inc (ADMS)
The Reporting Persons have entered into a Joint Filing Agreement, dated October 10, 2017, a copy of which is filed with this Schedule 13G/A as Exhibit A, pursuant to which the Reporting Persons have agreed...
13G Filing: Armistice Capital and Adamas Pharmaceuticals Inc (ADMS)
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing...
Billionaire Hedge Funds
